Open-angle Glaucoma
📧 Sign up to get email alerts when something new happens for Open-angle Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: A Phase III Multinational Multicenter Investigator-Masked Randomized Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase III multinational, investigator-masked, active-controlled trial comparing DE-130A with Xalatan (latanoprost) in open-angle glaucoma or…
-
CLINICAL_TRIALS withdrawal · 2024-05-20Clinical Trial Update: Effect of Negative Pressure on Pattern Electroretinography Readings [NA]
A clinical trial examining the effect of negative pressure on pattern electroretinography readings in glaucoma-related conditions has been w…
-
FDA approval · 2024-05-16FDA Approved: BRIMONIDINE TARTRATE/TIMOLOL MALEATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's generic fixed-dose combination eye drops containing brimonidine tartrate and timolol maleate for reducing intraocula…
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing Bimatoprost Sustained Release (SR) with selective laser trabeculoplasty (SLT) in adults with open-angle glaucoma or …
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]
Phase 1/2 safety and efficacy study of JV-GL1 in open-angle glaucoma or ocular hypertension has been suspended.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial [Phase 3]
NAMinG is a phase III, randomized, placebo-controlled trial evaluating nicotinamide for open-angle glaucoma, with recruitment ongoing across…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Additional Long-Term Follow-up for Subjects Implanted With a CyPass® Micro-Stent [NA]
Long-term follow-up results for subjects implanted with the CyPass Micro-Stent were posted, providing additional data in primary open-angle …
-
FDA approval · 2024-04-25FDA Approved: BRINZOLAMIDE — Supplemental Application (Oceanside Pharmaceuticals.)
The FDA approved a supplemental application for Brinzolamide submitted by Oceanside Pharmaceuticals. The approval concerns the generic drug …
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Nebivolol 0.5, 1.0, or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension [Phase 2]
Phase 2 trial comparing nebivolol and timolol suspensions to timolol solution for open-angle glaucoma and ocular hypertension; results poste…
-
FDA approval · 2024-03-29FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION, 0.004% — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for travoprost ophthalmic solution 0.004% by Mylan Pharmaceuticals, expanding access to a generic pr…
-
CLINICAL_TRIALS trial_result · 2024-03-22Clinical Trial Update: PRESERFLO® MicroShunt Extension Study
Completion update for the PRESERFLO MicroShunt extension study in primary open-angle glaucoma with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT [Phase 3]
A Phase III trial comparing DE-117 ophthalmic solution to latanoprost for safety and efficacy in open-angle glaucoma or ocular hypertension …
-
FDA approval · 2024-03-04FDA Approved: BRIMONIDINE — Original Application (Sandoz Inc)
The FDA approved Sandoz's original ANDA for brimonidine tartrate ophthalmic solution, establishing a generic version of this glaucoma medica…
-
FDA approval · 2024-02-20FDA Approved: DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALETAE — Supplemental Application (Indoco Remedies Limited)
FDA approved a supplemental application for a dorzolamide hydrochloride-timolol maleate eye drop manufactured by Indoco Remedies Limited.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension [Phase 3]
Phase 3 trial comparing BREMEN Eye Drops to Combigan for ocular hypertension and primary open-angle glaucoma has completed.
-
FDA approval · 2024-02-20FDA Approved: DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC — Supplemental Application (Florida Pharmaceutical Products, LLC)
FDA approved a supplemental application for dorzolamide hydrochloride ophthalmic solution filed by Florida Pharmaceutical Products, LLC.
-
FDA approval · 2024-02-13FDA Approved: BIMATOPROST — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for bimatoprost from Apotex Corp., authorizing a regulatory change under the ANDA framework.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 clinical trial update for a therapeutic equivalence study in primary open-angle glaucoma or ocular hypertension; results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: A Phase 2 Double-masked Study of VVN539 in Subjects With Elevated Intraocular Pressure [Phase 2]
Phase 2 double-masked trial of VVN539 in subjects with elevated intraocular pressure has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Comparing Preoperative Injection of Mitomycin-C vs. Intraoperative Injection of Mitomycin-C vs. Topical Application of Mitomycin-C (Conventional Use) in Trabeculectomy [Phase 4]
Phase 4 trial comparing preoperative, intraoperative, and topical mitomycin-C use in trabeculectomy for open-angle glaucoma; study terminate…
-
FDA approval · 2023-12-27FDA Approved: LATANOPROST — Supplemental Application (Bausch & Lomb Incorporated)
The FDA approved a supplemental application for latanoprost filed by Bausch & Lomb Incorporated.
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: A Randomized, Open-label, Active-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-angle Glaucoma or Ocular Hypertension [Phase 2]
Phase 2a randomized trial evaluating the efficacy and safety of TFC-003 in primary open-angle glaucoma or ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension [Phase 2]
A Phase 2 clinical trial update for Travoprost ophthalmic topical cream addressing open-angle glaucoma and ocular hypertension is in progres…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: A Comparative Confirmatory Study of STN1012600 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 confirmatory trial evaluating STN1012600 in adults with primary open-angle glaucoma or ocular hypertension has completed.
-
FDA approval · 2023-11-28FDA Approved: BIMATOPROST — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for bimatoprost filed by Alembic Pharmaceuticals Limited.